Predict your next investment

Venture Capital
cdpventurecapital.it

See what CB Insights has to offer

Investments

81

Portfolio Exits

1

Funds

6

About CDP Venture Capital SGR

CDP Venture Capital SGR is a venture capital firm based in Rome, Italy.

CDP Venture Capital SGR Headquarter Location

Via Arduino, 22

Rome, 00162,

Italy

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest CDP Venture Capital SGR News

Kither Biotech Raises €18.5M in Series B Funding

Mar 29, 2022

Kither Biotech , a Turin, Italy-based biopharmaceutical company developing novel therapies for rare respiratory diseases, raised €18.5m in Series B financing round. The round was co-led by new investors Claris Ventures and 2 Invest, with participation from 3B Future Health Fund and Alef 6 and existing investors CDP Venture Capital SGR, Italian Angels for Growth, Ersel, Club degli Investitori and ACE Venture. Pietro Puglisi, Partner at Claris Ventures and Heikki Lanckriet, CEO of 4BaseBio will join Kither’s Board of Directors. The company intends to use the funds for the clinical development of its lead product KIT2014, a novel cell-permeable peptide for the treatment of cystic fibrosis (CF) that works to modulate cyclic adenosine monophosphate (cAMP) levels inside cells, and to begin expanding and diversifying its pipeline of products for the treatment of rare pulmonary diseases by launching the pre-clinical development of KITCL27, a small molecule PI3K inhibitor pro-drug being developed as a monotherapy for idiopathic pulmonary fibrosis. cAMP levels are directly associated with the pathogenesis of CF including mucus accumulation, inflammation, and bronchoconstriction. KIT2014 is currently being developed as an add-on to the current standard of care enabling improved efficacy by directly focusing on the most significant ailments of CF patients, delivered directly to the lungs as an inhaled therapy. The Company expects to complete pre-clinical studies in 2022 and begin a Phase 1/2A clinical trial of KIT2014 soon thereafter. Founded by Prof. Alessandra Ghigo, Prof. Emilio Hirsch, Prof. Alberto Bardelli and Marco Kevin Malisani and led by newly appointed CEO Dr. Vincent Metzler, Kither Biotech is a biopharma company which aims to identify and develop new drug candidates for the treatment of rare pulmonary diseases, with specific focus on cystic fibrosis and idiopathic pulmonary fibrosis. A spin-off from the University of Turin, the company actively collaborates with the Molecular Biotechnology Center (University of Turin) and other research centres in the world. Kither has developed a pipeline of treatments currently under preclinical development, with programs in cystic fibrosis, idiopathic pulmonary fibrosis and other respiratory diseases. Dr. Metzler has served on the Board of Directors of Kither since June 2020, bringing more than 20 years of experience in commercial operations in pharma and biotech. Prior to joining Kither, Dr. Metzler was Vice President, Head of Marketing and Commercial Operations, Europe, at immunotherapy company Atara Biotherapeutics, and a member of the Executive Leadership Team of Wilson Therapeutics, a Swedish biotech clinical-stage company. Following the appointment of Dr. Metzler as Chief Executive Officer, current CEO Marco Kevin Malisani transitions to the role of Chief Financial Officer and remains a member of the Board of Directors. The Board of Directors will be chaired by Laura Iris Ferro, early investor in Kither and founder of Gentium, acquired by Jazz Pharmaceuticals for $1bn. FinSMEs 29/03/2022

CDP Venture Capital SGR Investments

81 Investments

CDP Venture Capital SGR has made 81 investments. Their latest investment was in Marshmallow Games as part of their Unattributed VC on June 6, 2022.

CBI Logo

CDP Venture Capital SGR Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/21/2022

Unattributed VC

Marshmallow Games

$2.11M

Yes

1

5/16/2022

Seed VC

Flyted

$1.31M

Yes

1

4/29/2022

Seed VC - II

Besafe Rate

$1.26M

No

1

4/26/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

4/22/2022

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/21/2022

5/16/2022

4/29/2022

4/26/2022

4/22/2022

Round

Unattributed VC

Seed VC

Seed VC - II

Seed VC

Unattributed VC

Company

Marshmallow Games

Flyted

Besafe Rate

Subscribe to see more

Subscribe to see more

Amount

$2.11M

$1.31M

$1.26M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

CDP Venture Capital SGR Portfolio Exits

1 Portfolio Exit

CDP Venture Capital SGR has 1 portfolio exit. Their latest portfolio exit was Plurima on March 18, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/18/2022

Corporate Majority

$99M

2

Date

3/18/2022

Exit

Corporate Majority

Companies

Valuation

$99M

Acquirer

Sources

2

CDP Venture Capital SGR Fund History

6 Fund Histories

CDP Venture Capital SGR has 6 funds, including Forward Factory.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/14/2021

Forward Factory

$9.76M

1

9/13/2021

Fondo Corporate Partners I

$99M

10

5/28/2021

Technology Transfer Fund

$99M

10

Boost Innovation Fund

$99M

10

Evoluzione Fund

$99M

10

Closing Date

12/14/2021

9/13/2021

5/28/2021

Fund

Forward Factory

Fondo Corporate Partners I

Technology Transfer Fund

Boost Innovation Fund

Evoluzione Fund

Fund Type

Status

Amount

$9.76M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

CDP Venture Capital SGR Team

2 Team Members

CDP Venture Capital SGR has 2 team members, including current Senior Partner, Stefano Molino.

Name

Work History

Title

Status

Stefano Molino

Innogest Capital, and Fondazione Torino Wireless

Senior Partner

Current

Mario Scuderi

Telecom Italia, BIP Consulting, Sistema Investimenti, and H. Lundbeck

Senior Partner

Current

Name

Stefano Molino

Mario Scuderi

Work History

Innogest Capital, and Fondazione Torino Wireless

Telecom Italia, BIP Consulting, Sistema Investimenti, and H. Lundbeck

Title

Senior Partner

Senior Partner

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.